1 / 1

Table 2 Unsuccessful or terminated phase III trials with anti‑VEGF pathway agents

Table 2 Unsuccessful or terminated phase III trials with anti‑VEGF pathway agents. Ebos, J. M. L. & Kerbel, R. S. (2011) Antiangiogenic therapy: impact on invasion, disease progression, and metastasis Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2011.21.

erasto
Download Presentation

Table 2 Unsuccessful or terminated phase III trials with anti‑VEGF pathway agents

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Table 2Unsuccessful or terminated phase III trials with anti‑VEGF pathway agents Ebos, J. M. L. & Kerbel, R. S. (2011)Antiangiogenic therapy: impact on invasion, disease progression, and metastasis Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2011.21

More Related